Pharmacological versus endoscopic therapy in the prevention of variceal hemorrhage: And the winner is...

Hepatology

Volumn 50, Issue 3, 2009, Pages 674-677

  Bosch, Jaime ^a   Garcia Tsao, Guadalupe ^b  

^a UNIVERSITY OF BARCELONA   (Spain)

^b YALE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARVEDILOL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; ISOSORBIDE MONONITRATE; NADOLOL; PRAZOSIN; PROPRANOLOL;

CLINICAL TRIAL; DRUG EFFICACY; DRUG WITHDRAWAL; DYSPNEA; EDITORIAL; ENDOSCOPIC BAND LIGATION; ENDOSCOPIC SCLEROTHERAPY; ENDOSCOPIC SURGERY; ESOPHAGUS VARICES BLEEDING; FATIGUE; HUMAN; INTERMETHOD COMPARISON; PORTAL HYPERTENSION; PREVENTION STUDY; PRIORITY JOURNAL; TREATMENT RESPONSE; WEAKNESS; ESOPHAGUS VARICES; GASTROINTESTINAL ENDOSCOPY; GASTROINTESTINAL HEMORRHAGE; METHODOLOGY; NOTE; RANDOMIZED CONTROLLED TRIAL; SCLEROTHERAPY;

ADRENERGIC BETA-ANTAGONISTS; ENDOSCOPY, GASTROINTESTINAL; ESOPHAGEAL AND GASTRIC VARICES; GASTROINTESTINAL HEMORRHAGE; HUMANS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SCLEROTHERAPY;

EID: 70349237059     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.23164     Document Type: Editorial

References (25)

1. D'Amico G, Pagliaro L, Bosch J. The treatment of portal hypertension: a meta-analytic review. HEPATOLOGY 1995;22:332-354.
2. de Franchis R, Pascal JP, Burroughs AK, Henderson JM, Fleig W, Groszmann RJ, et al. Definitions, methodology and therapeutic strategies in portal hypertension. A Consensus Development Workshop. J Hepatol 1992;15:256-261.
3. Garcia-Tsao G, Sanyal AJ, Grace ND, Carey W. Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis. HEPATOLOGY 2007;46:922-938. (Pubitemid 47436138)
4. Bosch J, Berzigotti A, Garcia-Pagan JC, Abraldes JG. The management of portal hypertension: rational basis, available treatments and future options. J Hepatol 2008;48(Suppl. 1):S68-S92.
5. Poynard T, Cales P, Pasta L, Ideo G, Pascal JP, Pagliaro L, et al. Beta-adrenergic antagonists in the prevention of first gastrointestinal bleeding in patients with cirrhosis and oesophageal varices. An analysis of data and prognostic factors in 598 patients from four randomized clinical trials. N Engl J Med 1991;324:1532-1538.
6. D'Amico G, Pagliaro L, Bosch J. Pharmacological treatment of portal hypertension: an evidence-based approach. Semin Liver Dis 1999;19:475-505. (Pubitemid 30032646)
7. Perez-Ayuso RM, Pique JP, Bosch J, Panes J, Gonzalez A, Perez R, et al. Propranolol in prevention of recurrent bleeding from severe portal hypertensive gastropathy in cirrhosis. Lancet 1991;337:1431-1434.
8. Groszmann RJ, Wongcharatrawee S. The hepatic venous pressure gradient: Anything worth doing should be done right. HEPATOLOGY 2004;39:280-283. (Pubitemid 38222164)
9. Feu F, Garcia-Pagan JC, Bosch J, Luca A, Teres J, Escorsell A, et al. Relation between portal pressure response to pharmacotherapy and risk of recurrent variceal haemorrhage in patients with cirrhosis. Lancet 1995;346:1056-1059.
10. D'Amico G, Garcia-Pagan JC, Luca A, Bosch J. HVPG reduction and prevention of variceal bleeding in cirrhosis. A systematic review. Gastroenterology 2006;131:1611-1624.
11. Abraldes JG, Tarantino I, Turnes J, Garcia-Pagan JC, Rodes J, Bosch J. Hemodynamic response to pharmacological treatment of portal hypertension and long-term prognosis of cirrhosis. HEPATOLOGY 2003;37:902-908. (Pubitemid 36397403)
12. Turnes J, Garcia-Pagan JC, Abraldes JG, Hernandez-Guerra M, Dell'era A, Bosch J. Pharmacological reduction of portal pressure and long-term risk of first variceal bleeding in patients with cirrhosis. Am J Gastroenterol 2006;101:506-512. (Pubitemid 43340926)
13. Longacre AV, Imaeda A, Garcia-Tsao G, Fraenkel L. A pilot project examining the predicted preferences of patients and physicians in the primary prophylaxis of variceal hemorrhage. HEPATOLOGY 2008;47:169-176. (Pubitemid 351171054)
14. Banares R, Moitinho E, Piqueras B, Casado M, Garcia-Pagan JC, De Diego A, et al. Carvedilol, a new nonselective beta-blocker with intrinsic anti-Alpha1-adrenergic activity, has a greater portal hypotensive effect than propranolol in patients with cirrhosis. HEPATOLOGY 1999;30:79-83. (Pubitemid 29300572)
15. Banares R, Moitinho E, Matilla A, Garcia-Pagan JC, Lampreave JL, Piera C, et al. Randomized comparison of long-term carvedilol and propranolol administration in the treatment of portal hypertension in cirrhosis. HEPATOLOGY 2002;36:1367-1373. (Pubitemid 35403527)
16. Tripathi D, Therapondos G, Lui HF, Stanley AJ, Hayes PC. Haemodynamic effects of acute and chronic administration of low-dose carvedilol, a vasodilating beta-blocker, in patients with cirrhosis and portal hypertension. Aliment Pharmacol Ther 2002;16:373-380. (Pubitemid 34214515)
17. Albillos A, Garcia-Pagan JC, Iborra J, Bandi JC, Cacho G, Perez-Paramo M, et al. Propranolol plus prazosin compared with propranolol plus isosorbide-5-mononitrate in the treatment of portal hypertension. Gastroenterology 1998;115:116-123. (Pubitemid 28307295)
18. Abraldes JG, Albillos A, Banares R, Turnes J, Gonzalez R, Garcia-Pagan JC, et al. Simvastatin lowers portal pressure in patients with cirrhosis and portal hypertension: a randomized controlled trial. Gastroenterology 2009;136:1651-1658.
19. Thalheimer U, Bosch J, Burroughs AK. How to prevent varices from bleeding: shades of grey-the case for nonselective beta blockers. Gastroenterology 2007;133:2029-2036. (Pubitemid 350180826)
20. Laine L, Cook D. Endoscopic ligation compared with sclerotherapy for treatment of esophageal variceal bleeding. A meta-analysis. Ann Intern Med 1995;123:280-287.
21. Khuroo MS, Khuroo NS, Farahat KL, Khuroo YS, Sofi AA, Dahab ST. Meta-analysis: endoscopic variceal ligation for primary prophylaxis of oesophageal variceal bleeding. Aliment Pharmacol Ther 2005;21:347-361. (Pubitemid 40313938)
22. Garcia-Pagan JC, Bosch J. Endoscopic band ligation in the treatment of portal hypertension. Nat Clin Pract Gastroenterol Hepatol 2005;2:526-535. (Pubitemid 43135271)
23. Gluud LL, Klingenberg S, Nikolova D, Gluud C. Banding ligation versus beta-blockers as primary prophylaxis in esophageal varices: systematic review of randomized trials. Am J Gastroenterol 2007;102:2842-2848. (Pubitemid 350179353)
24. Tripathi D, Ferguson JW, Kochar N, Leithead JA, Therapondos G, McAvoy NC, et al. Randomized controlled trial of carvedilol versus variceal band ligation for the preventionof the first variceal bleed. HEPATOLOGY 2009; doi:10.1002/hep.23045.
25. Schepke M, Kleber G, Nurnberg D, Willert J, Koch L, Veltzke-Schlieker W, et al. Ligation versus propranolol for the primary prophylaxis of variceal bleeding in cirrhosis. HEPATOLOGY 2004;40:65-72. (Pubitemid 38868924)